[Clinical experience with Encephabol (author's transl)].
The author reports on a clinical study with the neuro-dynamic agent Encephabol (pyritinol, pyrithioxine) in a total of 317 patients with organic psychosyndrome of various genesis. The therapeutic effect obtained is related by the author to the mode of administration used (oral, parenteral and combined), to the dosage, and duration of treatment, and is discussed.
D000284:Administration, Oral; D000328:Adult; D001925:Brain Damage, Chronic / Q000188:drug therapy; D002986:Clinical Trials as Topic; D004305:Dose-Response Relationship, Drug; D004341:Drug Evaluation; D006801:Humans; D007263:Infusions, Parenteral; D001523:Mental Disorders / Q000188:drug therapy*; D008875:Middle Aged; D019965:Neurocognitive Disorders / Q000188:drug therapy; D011725:Pyridines / Q000627:therapeutic use*; D011746:Pyrithioxin / Q000008:administration & dosage / Q000627:therapeutic use*
D011725:Pyridines; D011746:Pyrithioxin
Klinische Erfahrungen mit Encephabol